| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6191616 | European Journal of Surgical Oncology (EJSO) | 2015 | 7 Pages |
Abstract
D3 reverses the negative impact of diffuse histotype on relapses, especially on locoregional recurrences. Therefore D3 could be considered a valid therapeutic option in histotype-oriented tailored treatment of AGC.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
G. de Manzoni, G. Verlato, M. Bencivenga, D. Marrelli, A. Di Leo, S. Giacopuzzi, C. Cipollari, F. Roviello,